Loading
CD8 marks the T cells that kill: the ones that recognise a cancer cell and destroy it. How many CD8 cells sit inside a tumour, and where, is one of the few immune measurements that predicts how a cancer will behave.
CD8 is the co-receptor that binds MHC class I and defines cytotoxic T cells, the cells that kill a target directly. It is the marker behind the phrase 'tumour-infiltrating lymphocytes' and behind the distinction between a hot and a cold tumour. Its density is prognostic rather than merely descriptive: the international consensus Immunoscore study quantified CD3 and CD8 densities in the tumour centre and the invasive margin in 1,885 stage I/II colon cancers across Canada, the United States, Europe and Asia, and a high Immunoscore carried the lowest risk of recurrence in both cohorts. CD8 is a two-chain receptor; CD8A is the alpha chain given here and CD8B (HGNC:1707) the beta.
In plain words · CD8 marks the T cells that kill: the ones that recognise a cancer cell and destroy it. How many CD8 cells sit inside a tumour, and where, is one of the few immune measurements that predicts how a cancer will behave.
CD8 marks the T cells that kill: the ones that recognise a cancer cell and destroy it. How many CD8 cells sit inside a tumour, and where, is one of the few immune measurements that predicts how a cancer will behave.
Co-receptor on cytotoxic T cells; binds MHC class I and marks the killing lineage. The beta chain is CD8B (HGNC:1707).
No product in this corpus aims at CD8 yet. Because it sits on the outside of the cell, it can be reached from the bloodstream: antibodies flag the cell, ADCs deliver a toxin, radioligands deliver radiation, and CAR-T or bispecifics bring a T cell.
Co-receptor on cytotoxic T cells; binds MHC class I and marks the killing lineage. The beta chain is CD8B (HGNC:1707).
Query for this target: (TITLE:"CD8" OR ABSTRACT:"CD8" OR TITLE:"CD8A" OR ABSTRACT:"CD8A" OR TITLE:"CD8a" OR ABSTRACT:"CD8a" OR TITLE:"CD8 alpha" OR ABSTRACT:"CD8 alpha" OR TITLE:"T8" OR ABSTRACT:"T8") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CD8, not a curated reading list.
Shares T-cell exhaustion and CAR-T persistence, T cell and the tag immune-marker.
Shares CD4 and the tag immune-marker.
Shares CD4 and the tag immune-marker.
Shares T cell and the tag immune-marker.
Shares T cell and the tag immune-marker.
Shares Hot vs cold tumours, PD-1.
Shares CXCR3, Hot vs cold tumours.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/